Emory University Heron Therapeutics, Inc. Transaction History

Emory University

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$17.42 - $26.61 $870,547 - $1.33 Million	-49,974 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$16.36 - $21.39 $1.29 Million - $1.69 Million	-79,046 Reduced 61.27%	49,974 $925,000
Q2 2019 Aug 14, 2019	BUY	$16.93 - $26.22 $720,252 - $1.12 Million	42,543 Added 49.2%	129,020 $2.4 Million
Q1 2019 May 09, 2019	BUY	$23.15 - $28.34 $51,207 - $62,688	2,212 Added 2.63%	86,477 $2.11 Million
Q4 2018 Feb 12, 2019	BUY	$22.03 - $32.01 $1.86 Million - $2.7 Million	84,265 New	84,265 $2.19 Million

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $127M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Emory University, based on Form 13F filings with the SEC.

Stay updated on Emory University with notifications on news.